China Resources Double-Crane Pharmaceutical Co Ltd (600062) - Total Liabilities

Latest as of September 2025: CN¥4.85 Billion CNY ≈ $710.14 Million USD

Based on the latest financial reports, China Resources Double-Crane Pharmaceutical Co Ltd (600062) has total liabilities worth CN¥4.85 Billion CNY (≈ $710.14 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 600062 cash flow metrics to assess how effectively this company generates cash.

China Resources Double-Crane Pharmaceutical Co Ltd - Total Liabilities Trend (1994–2024)

This chart illustrates how China Resources Double-Crane Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of China Resources Double-Crane Pharmaceuti to evaluate the company's liquid asset resilience ratio.

China Resources Double-Crane Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of China Resources Double-Crane Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Soleno Therapeutics Inc NASDAQ:SLNO	USA	$113.72 Million
Sigurd Microelectronics Corp TW:6257	Taiwan	NT$17.32 Billion
American States Water Company NYSE:AWR	USA	$1.65 Billion
Brookfield Wealth Solutions Ltd. NYSE:BNT	USA	$135.91 Billion
Robert Half International Inc NYSE:RHI	USA	$1.56 Billion
Corporativo Fragua S.A.B. de C.V MX:FRAGUAB	Mexico	MX$15.09 Billion
Diebold Nixdorf, Incorporated NYSE:DBD	USA	$2.75 Billion
Gaon Cable KO:000500	Korea	₩791.47 Billion

Liability Composition Analysis (1994–2024)

This chart breaks down China Resources Double-Crane Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 600062 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.25	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.43	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.29	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how China Resources Double-Crane Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for China Resources Double-Crane Pharmaceutical Co Ltd (1994–2024)

The table below shows the annual total liabilities of China Resources Double-Crane Pharmaceutical Co Ltd from 1994 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥5.57 Billion ≈ $815.69 Million	+53.09%
2023-12-31	CN¥3.64 Billion ≈ $532.82 Million	-2.98%
2022-12-31	CN¥3.75 Billion ≈ $549.17 Million	+17.30%
2021-12-31	CN¥3.20 Billion ≈ $468.19 Million	+5.26%
2020-12-31	CN¥3.04 Billion ≈ $444.77 Million	+16.89%
2019-12-31	CN¥2.60 Billion ≈ $380.51 Million	+8.46%
2018-12-31	CN¥2.40 Billion ≈ $350.84 Million	+50.85%
2017-12-31	CN¥1.59 Billion ≈ $232.57 Million	+32.11%
2016-12-31	CN¥1.20 Billion ≈ $176.04 Million	-9.49%
2015-12-31	CN¥1.33 Billion ≈ $194.50 Million	+42.17%
2014-12-31	CN¥934.93 Million ≈ $136.81 Million	-18.32%
2013-12-31	CN¥1.14 Billion ≈ $167.50 Million	-36.44%
2012-12-31	CN¥1.80 Billion ≈ $263.55 Million	+3.89%
2011-12-31	CN¥1.73 Billion ≈ $253.69 Million	+35.49%
2010-12-31	CN¥1.28 Billion ≈ $187.24 Million	+8.24%
2009-12-31	CN¥1.18 Billion ≈ $172.99 Million	+5.69%
2008-12-31	CN¥1.12 Billion ≈ $163.68 Million	-14.53%
2007-12-31	CN¥1.31 Billion ≈ $191.52 Million	+3.53%
2006-12-31	CN¥1.26 Billion ≈ $184.98 Million	-32.55%
2005-12-31	CN¥1.87 Billion ≈ $274.23 Million	-18.45%
2004-12-31	CN¥2.30 Billion ≈ $336.26 Million	-9.57%
2003-12-31	CN¥2.54 Billion ≈ $371.86 Million	+26.33%
2002-12-31	CN¥2.01 Billion ≈ $294.35 Million	+60.12%
2001-12-31	CN¥1.26 Billion ≈ $183.83 Million	+99.76%
2000-12-31	CN¥628.89 Million ≈ $92.03 Million	+32.79%
1999-12-31	CN¥473.60 Million ≈ $69.30 Million	+137.31%
1998-12-31	CN¥199.57 Million ≈ $29.20 Million	+96.08%
1997-12-31	CN¥101.78 Million ≈ $14.89 Million	+109.89%
1996-12-31	CN¥48.49 Million ≈ $7.10 Million	+66.25%
1995-12-31	CN¥29.17 Million ≈ $4.27 Million	-19.92%
1994-12-31	CN¥36.42 Million ≈ $5.33 Million	--

About China Resources Double-Crane Pharmaceutical Co Ltd

SHG:600062 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.71 Billion

CN¥18.54 Billion CNY

Market Cap Rank

#5242 Global

#1034 in China

Share Price

CN¥17.85

Change (1 day)

-0.61%

52-Week Range

CN¥17.70 - CN¥21.22

All Time High

CN¥33.06